GGrantIndex
← Leaderboards

Wulf Palinski

University Of California San Diego

$6,771,384
Attributed
$6,771,384
Total exposure
4
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $941.6K · FY200511
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11

Funding mix

By agency

NIH$6,771,384 · 4

By mechanism

R01$3,864,279 · 2
P50$2,907,105 · 2

Top collaborators

No co-investigators on record.

Most similar at University Of California San Diego

Same institution · by research overlap

Others in their field

Top investigators on “Antioxidants

Research focus

AntioxidantsOxidative StressMicroscopyAtherosclerotic PlaqueHypercholesterolemiaImmunocytochemistryLaboratory MouseLow Density LipoproteinAntigensAtherosclerosisOxidationLow Density Lipoprotein ReceptorActive ImmunizationPeroxisome Proliferator Activated ReceptorApolipoprotein EAortaAnimal ModelAgonistAdultCardiovascular DiseasesBiomedical FacilityAffectBlood CirculationAntibodies

Grant awards (22)

Developmental immune programming and postnatal atherosclerosis$472,614
R01 · FY2011 · HL · contact PI
Developmental immune programming and postnatal atherosclerosis$477,394
R01 · FY2010 · HL · contact PI
Developmental immune programming and postnatal atherosclerosis$477,145
R01 · FY2009 · HL · contact PI
Developmental immune programming and postnatal atherosclerosis$467,446
R01 · FY2008 · HL · contact PI
Fetal Determinants of Atherosclerosis$499,334
R01 · FY2006 · HL · contact PI
Oxidation, immune-modulation and atherogenesis in vivo$229,216
P50 · FY2006 · HL · contact PI
Core C-- Morphology Core$126,879
P50 · FY2006 · HL · contact PI
Fetal Determinants of Atherosclerosis$496,453
R01 · FY2005 · HL
Oxidation, immune-modulation and atherogenesis in vivo$321,988
P50 · FY2005 · HL
Core C-- Morphology Core$123,182
P50 · FY2005 · HL
Fetal Determinants of Atherosclerosis$481,995
R01 · FY2004 · HL
Oxidation, immune-modulation and atherogenesis in vivo$313,026
P50 · FY2004 · HL
Core C-- Morphology Core$119,594
P50 · FY2004 · HL
Fetal Determinants of Atherosclerosis$491,898
R01 · FY2003 · HL
Oxidation, immune modulation and atherogenesis in vivo$265,067
P50 · FY2003 · HL
CORE--MORPHOLOGY$116,110
P50 · FY2003 · HL
Oxidation, immune modulation and atherogenesis in vivo$259,017
P50 · FY2002 · HL
CORE--MORPHOLOGY$112,728
P50 · FY2002 · HL
CORE--MORPHOLOGY$274,326
P50 · FY2001 · HL
ROLE OF MODIFIED LIPOPROTEINS AND THE IMMUNE SYSTEM IN ATHEROGENESIS$274,326
P50 · FY2001 · HL
CORE--MORPHOLOGY$185,823
P50 · FY2000 · HL
ROLE OF MODIFIED LIPOPROTEINS AND THE IMMUNE SYSTEM IN ATHEROGENESIS$185,823
P50 · FY2000 · HL